Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00ICD
|
|||
| Former ID |
DIB014952
|
|||
| Drug Name |
SH-529
|
|||
| Synonyms |
Glucoprime; GLYC-101; GLYC-101); Iloprost beta-cyclodextrin clathrate; Z-101; ZK-96944; (1-3)-(1-6)-beta-D-glucan,Glycotex
Click to Show/Hide
|
|||
| Indication | Peripheral vascular disease [ICD-11: BD4Z; ICD-10: I73.9; ICD-9: 443.9] | Phase 2 | [1] | |
| Company |
Bayer Schering Pharma AG; Novogen Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | TNF alpha production (TNFA produ) | Target Info | Modulator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Particulate beta-glucan induces TNF-alpha production in wound macrophages via a redox-sensitive NF- beta-dependent pathway. Wound Repair Regen. 2011 May-Jun;19(3):411-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.